Osaka, Japan

Tomohiro Kodama

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Boston Biomedical, Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomohiro Kodama. Retrieved from https://idiyas.com/inventor/tomohiro-kodama-us38nw0x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tomohiro Kodama: Innovator in Pharmaceutical Chemistry

Introduction

Tomohiro Kodama is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on heterocyclic compounds. His research focuses on developing new compounds that have potential therapeutic applications.

Latest Patents

Kodama holds a patent for a compound titled "Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivative." This patent discloses a compound represented by a specific formula, which includes various substituents that can enhance its pharmacological properties. The compound is designed to be a pharmacologically acceptable salt, indicating its potential use in medical applications.

Career Highlights

Kodama is currently employed at Boston Biomedical, Inc., where he continues to advance his research in drug development. His work is characterized by a commitment to innovation and a focus on creating compounds that can lead to new therapeutic options for patients.

Collaborations

Throughout his career, Kodama has collaborated with several talented individuals, including Shingo Tojo and Yosuke Takanashi. These collaborations have fostered a productive environment for research and development, allowing for the exchange of ideas and expertise.

Conclusion

Tomohiro Kodama's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in the field. His patent and ongoing work at Boston Biomedical, Inc. highlight his dedication to advancing medical science through the development of new compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…